August 24th 2023
Paris, August 24, 2023 – 6 pm CEST
CARMAT (FR0010907956, ALCAR), designer and developer of Aeson®, the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure, informs its shareholders that due to practical considerations, the publication of its half-year results, initially scheduled for September 13, 2023, will take place on September 25, 2023 after the market close.
On the same day, the Company will hold a videoconference in French and English. Times and connection details will be communicated to shareholders and the financial community shortly.